Anna Burkart Sadusky
About Anna Burkart Sadusky
Anna Burkart Sadusky is a Program Director at the National Institutes of Health, where she has worked since 2019. She has extensive experience in regulatory science and policy, having held various roles at the American Association for Cancer Research and Omeros Corporation.
Current Role at National Institutes of Health
Anna Burkart Sadusky serves as a Program Director at the National Institutes of Health (NIH) since 2019. In this role, she provides scientific leadership within the Division of Kidney, Urology, and Hematology at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Her responsibilities include directing and managing a regulatory science and policy portfolio, which involves overseeing FDA requirements and ensuring compliance with regulatory standards.
Previous Experience at American Association for Cancer Research
Sadusky held multiple positions at the American Association for Cancer Research (AACR) from 2015 to 2018. She began as the Associate Director of Science Policy for 11 months, followed by a year as the Associate Director of Regulatory Science and Policy. Subsequently, she served as the Director of Regulatory Science and Policy for two years. In these roles, she focused on developing policies that impact cancer research and regulatory science.
Educational Background
Sadusky earned her Bachelor of Arts in Biology from The Johns Hopkins University, where she studied from 1995 to 1999. She then pursued a PhD in Biochemistry, Molecular Biology, and Cell Biology at Northwestern University, completing her studies from 1999 to 2005. Additionally, she obtained a Certificate in Biomedical Regulatory Affairs from UW Professional & Continuing Education between 2014 and 2015, focusing on quality management and regulatory compliance.
Experience in Regulatory Science and Policy
Sadusky has extensive experience in regulatory science and policy, particularly in the biomedical field. She has directed and managed a regulatory science and policy portfolio, which includes overseeing FDA requirements. Her work has involved ensuring compliance with regulations for medical devices, drugs, and biologics, demonstrating her expertise in the field.
Research and Scientific Roles
Before her current position, Sadusky worked as a Staff Scientist and Senior Scientist at Omeros Corporation from 2011 to 2015. She also served as a Post-doctoral Fellow at the University of Washington and the National Institutes of Health from 2005 to 2011. These roles contributed to her scientific expertise and understanding of regulatory frameworks in biomedical research.